The Drug Safety Research Unit (DSRU) is an independent organization in the United Kingdom that conducts post-marketing drug safety and pharmacovigilance research.
DSRU performs observational studies and monitoring programs to evaluate real-world safety outcomes over long time horizons. Its research complements clinical trial safety data by capturing broader populations and routine-use conditions. Findings may inform risk management strategies, safety communications, and regulatory actions. Long-term safety evidence strengthens benefitñrisk understanding after product launch.